Abstract This paper concerns the design and rigorous in silico evaluation of a closed-loop hemorrhage resuscitation algorithm with blood pressure (BP) as controlled variable. A lumped-parameter control design model relating volume resuscitation input to blood volume (BV) and BP responses was developed and experimentally validated. Then, three alternative adaptive control algorithms were developed using the control design model: (i) model reference adaptive control (MRAC) with BP feedback, (ii) composite adaptive control (CAC) with BP feedback, and (iii) CAC with BV and BP feedback. To the best of our knowledge, this is the first work to demonstrate model-based control design for hemorrhage resuscitation with readily available BP as feedback. The efficacy of these closed-loop control algorithms was comparatively evaluated as well as compared with an empiric expert knowledge-based algorithm based on 100 realistic virtual patients created using a well-established physiological model of cardiovascular (CV) hemodynamics. The in silico evaluation results suggested that the adaptive control algorithms outperformed the knowledge-based algorithm in terms of both accuracy and robustness in BP set point tracking: the average median performance error (MDPE) and median absolute performance error (MDAPE) were significantly smaller by >99% and >91%, and as well, their interindividual variability was significantly smaller by >88% and >94%. Pending in vivo evaluation, model-based control design may advance the medical autonomy in closed-loop hemorrhage resuscitation.
more »
« less
This content will become publicly available on May 1, 2026
Development of a Virtual Patient Generator for Simulation of Vasopressor Resuscitation
Abstract This paper presents a virtual patient generator (VPG) intended to be used for preclinical in silico evaluation of autonomous vasopressor administration algorithms in the setting of experimentally induced vasoplegia. Our VPG consists of two main components: (i) a mathematical model that replicates physiological responses to experimental vasoplegia (induced by sodium nitroprusside (SNP)) and vasopressor resuscitation via phenylephrine (PHP) and (ii) a parameter vector sample generator in the form of a multidimensional probability density function (PDF) using which the parameters characterizing the mathematical model can be sampled. We developed and validated a mathematical model capable of predicting physiological responses to the administration of SNP and PHP. Then, we developed a parameter vector sample generator using a collective variational inference method. In a blind testing, the VPG developed by combining the two could generate a large number of realistic virtual patients (VPs), which could simulate physiological responses observed in all the experiments: on the average, 98.1% and 74.3% of the randomly generated VPs were physiologically legitimate and adequately replicated the test subjects, respectively, and 92.4% of the experimentally observed responses could be covered by the envelope formed by the subject-replicating VPs. In sum, the VPG developed in this paper may be useful for preclinical in silico evaluation of autonomous vasopressor administration algorithms.
more »
« less
- Award ID(s):
- 1748762
- PAR ID:
- 10575880
- Publisher / Repository:
- ASME
- Date Published:
- Journal Name:
- Journal of Dynamic Systems, Measurement, and Control
- Volume:
- 147
- Issue:
- 3
- ISSN:
- 0022-0434
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Abstract Physiological closed-loop control algorithms play an important role in the development of autonomous medical care systems, a promising area of research that has the potential to deliver healthcare therapies meeting each patient's specific needs. Computational approaches can support the evaluation of physiological closed-loop control algorithms considering various sources of patient variability that they may be presented with. In this article, we present a generative approach to testing the performance of physiological closed-loop control algorithms. This approach exploits a generative physiological model (which consists of stochastic and dynamic components that represent diverse physiological behaviors across a patient population) to generate a select group of virtual subjects. By testing a physiological closed-loop control algorithm against this select group, the approach estimates the distribution of relevant performance metrics in the represented population. We illustrate the promise of this approach by applying it to a practical case study on testing a closed-loop fluid resuscitation control algorithm designed for hemodynamic management. In this context, we show that the proposed approach can test the algorithm against virtual subjects equipped with a wide range of plausible physiological characteristics and behavior and that the test results can be used to estimate the distribution of relevant performance metrics in the represented population. In sum, the generative testing approach may offer a practical, efficient solution for conducting preclinical tests on physiological closed-loop control algorithms.more » « less
-
Zebrafish is a model organism that is receiving considerable attention in preclinical research. Particularly important is the use of zebrafish in behavioral pharmacology, where a number of high-throughput experimental paradigms have been proposed to quantify the effect of psychoactive substances consequences on individual and social behavior. In an effort to assist experimental research and improve animal welfare, we propose a mathematical model for the social behavior of groups of zebrafish swimming in a shallow water tank in response to the administration of psychoactive compounds to select individuals. We specialize the mathematical model to caffeine, a popular anxiogenic compound. Each fish is assigned to a Markov chain that describes transitions between freezing and swimming. When swimming, zebrafish locomotion is modeled as a pair of coupled stochastic differential equations, describing the time evolution of the turn-rate and speed in response to caffeine administration. Comparison with experimental results demonstrates the accuracy of the model and its potential use in the design of in-silico experiments.more » « less
-
Fluid resuscitation is an integral part of critical care for burn injury patients where the necessary infusion rate is determined based on patient’s urinary output (UO). Motivated by an increasing interest in model-based development and in silico testing of automated burn resuscitation algorithms, we are investigating mathematical modeling of hemodynamic responses to burn injury and resuscitation. The model consists of 3 main components: (1) multi-compartmental volume kinetics including vascular and interstitial fluids and the associated flow interactions, (2) burn-induced hemodynamic perturbation including alterations in tissue permeability and compliance as well as denaturation with protein release, and (3) renal regulatory function including glomerular filtration rate as a function of intravascular volume state and reabsorption function representing the UO dependence on vasopressin. Preliminary evaluation of the initial model with data collected from animals show that the model can reproduce general trend of hemodynamic responses anticipated from burn injury and resuscitation.more » « less
-
Abstract Significant advances have been made in the development of nanoparticles for cancer treatment in recent years. Despite promising results in preclinical animal models, cancer nanomedicines often fail in clinical trials. This failure rate could be reduced by defining stringent criteria for testing and quality control during the design and development stages, and by performing carefully planned preclinical studies in relevant animal models. This article discusses best practices for the evaluation of nanomedicines in murine tumor models. First, a recommended set of experiments to perform is introduced, including discussion of the types of data to collect during these studies. This is followed by an outline of various tumor models and their clinical relevance. Next, different routes of nanoparticle administration are overviewed, followed by a summary of important controls to include in in vivo studies of nanomedicine. Finally, animal welfare considerations are discussed, and an overview of the steps involved in achieving US Food and Drug Administration approval after animal studies are completed is provided. Researchers should use this report as a guideline for effective preclinical evaluation of cancer nanomedicine. As the community adopts best practices for in vivo testing, the rate of clinical translation of cancer nanomedicines is likely to improve.more » « less
An official website of the United States government
